The LRPAP1 gene helps guide certain receptors so they fold correctly and move to the right place inside cells. The protein made by this gene helps your cells handle signals and proteins in a controlled way, including in the eye. If both copies of the gene do not work properly, people can develop early, very high myopia, which means strong nearsightedness that often starts in childhood. LRPAP1 is mainly known in medical genetics rather than popular culture.

What is a gene?

Genes are sections of DNA that carry instructions your cells use to make molecules or direct processes in the body. Some genes provide the information needed to make proteins, the parts of cells that do much of the work. Others mainly regulate when certain processes happen, where they take place, and how active they are. Together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, and medications. For a closer look at this subject, you can find more in the LearnHub.

Overview

LRPAP1

Gene function

What if the gene works

The LRPAP1 gene helps cells fold and transport certain receptors to the cell surface. Its protein also keeps these receptors from binding too early inside the cell, which supports normal cell signaling and uptake.

Risk

What if the gene does not work

When the LRPAP1 gene works poorly, people can develop early onset high myopia, often with excessive eye length and variable reduced vision. Milder and more severe variants may influence how early it appears and how marked the eye changes become.

Treatment

What does that mean for your treatment

No LRPAP1-specific treatment or management approach is currently established, and pathogenic variants do not currently guide any disease-specific drug choice. Research is exploring how the LRPAP1 gene may influence eye growth, but this has not changed routine treatment.

Conditions associated with LRPAP1

Rare isolated myopia

Gene function

What if the gene works

Inside your cells, the LRPAP1 gene helps certain receptors that let cells take in and move materials get ready for work. It acts as a temporary helper during folding and transport, which is central to how the LRPAP1 gene supports receptor handling inside cells.

Protein shaping

LRPAP1 helps certain receptor proteins fold into a stable shape while they are being made inside the cell. This early support helps those receptors reach later steps in a form the cell can use.

Cell transport

This gene helps guide developing receptors through the endoplasmic reticulum (the cell's protein workshop) and onward through the cell's delivery route. That movement helps place receptors where they are meant to work.

Early shielding

The LRPAP1 protein briefly covers key parts of these receptors so they do not bind other molecules too soon. This keeps their preparation more orderly before they reach their final location.

What is a variant?

A genetic variant is a minor difference in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Most variants do not cause any noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.

Variant illustration

Genetic variants

What if the gene does not work

Variants in the LRPAP1 gene can make too little protein, destabilize it, or add an early stop signal that leaves it shortened and unable to interact normally with other proteins. Milder changes may leave some activity, while more severe variants can remove most function, so LRPAP1 gene variants and protein function can vary from partly reduced to nearly absent. When both copies are affected, this loss is linked to early, often marked high myopia.

How variants are linked to conditions

Pathogenic variants in both copies of the LRPAP1 gene cause a rare inherited form of severe early-onset high myopia. People with high myopia linked to the LRPAP1 gene usually become very nearsighted in childhood, and some may later develop retinal changes or other eye problems seen more often with high myopia.

A variant is not necessarily a diagnosis

Gene variants are a normal feature of human biology and are common across the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental influences are involved. In some situations, though, one well-characterized variant in a specific gene is enough to confirm a diagnosis.

Dr. Wallerstorfer Dr. Wallerstorfer

Are there things that can increase or change my risk?

There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the LRPAP1 gene itself. In families with a disease-causing LRPAP1 change, the main factor is whether the change was inherited, while everyday habits have not been shown to clearly change that genetic risk.

Inheritance of LRPAP1 variants

LRPAP1-related eye conditions follow an autosomal recessive inheritance pattern. This means a person usually inherits one altered copy of the LRPAP1 gene from each parent, and parents who carry one copy typically do not have the condition themselves. When both parents are carriers, each pregnancy has a 25% chance of resulting in a child with the condition, a 50% chance of a child who is a carrier, and a 25% chance of a child with two non-altered copies. This LRPAP1 gene inheritance pattern affects sons and daughters equally.

What does my LRPAP1 result mean for my family?

For families with an LRPAP1-related eye condition, the usual pattern is recessive, which means close relatives may carry the same gene change even if they do not have symptoms. Brothers and sisters can sometimes also be affected, while parents are often healthy carriers. This can matter for family planning and for relatives who have strong nearsightedness or want to better understand their own chance of being a carrier.


Genetic information


Genetic testing

How you find out about variants

To find out whether you carry a variant in the LRPAP1 gene, a lab can analyze DNA from a blood, saliva, or cheek swab sample. This is how genetic testing for LRPAP1 variants works: the lab reads the gene’s DNA code and checks for changes in the parts of the gene it examines.

When should I consider getting a genetic test?

Genetic testing for the LRPAP1 gene may be worth considering if someone has very severe nearsightedness that starts in childhood, especially if brothers, sisters, or other relatives are also affected. A result can help explain the cause and clarify whether this inherited eye condition runs in the family.

A genetic result is only one part of your health story

A genetic result can provide valuable insight, but how much it explains varies by the condition and the kind of variant involved. Lifestyle, environment, age, and medical history are among the many factors that influence how the body functions over time. In some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, genetic results can help put individual experiences into context.

Dr. Wallerstorfer Dr. Wallerstorfer

Pharmacogenetics

How variants shape your response to medicine

Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, or moves a drug, so the same treatment may work well for one person but less well for another. This is a common part of normal human variation and can influence both how effective a medicine feels and how sensitive someone is to side effects.

What is Pharmacogenetics?

Pharmacogenetics examines how differences in genes can shape the way a person responds to medication. It focuses on relationships between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes affect how strongly a drug works or how the body handles it. This information can support treatment choices that are more informed and more individualized. More details on this topic are available in the LearnHub.


Drugs influenced by the LRPAP1 gene

There are 0 Drugs associated with LRPAP1
Currently no available information

When should I seek medical advice?

There is not yet a broadly confirmed role for this gene in how people respond to medicines, so questions about side effects, new symptoms, or whether a treatment is right for you are best discussed with your doctor.

Literature

DISCLAIMER: The materials present on Genopedia.com, such as text, images, graphics, among other items (“Content”), are shared purely for informational reasons. This content should not replace professional health advice, medical diagnoses, or treatment procedures. Whenever you have health concerns or questions, it’s always recommended to engage with your doctor or another appropriate healthcare provider. If you read something on the Genopedia.com site, do not neglect professional medical counsel or delay in obtaining it. In case you believe you’re dealing with a medical crisis, get in touch with your medical professional or call emergency without delay. Genopedia.com doesn’t advocate for any particular medical tests, healthcare providers, products, methods, beliefs, or other data that could be discussed on the site. Please also note that the content, originally written in English and in part created with the help of artificial intelligence, is provided without any warranty, and any reliance on information offered by Genopedia.com, its staff, contributors invited by Genopedia.com, or site users is entirely at your own risk.
Genopedia © 2026 all rights reserved